Companies › CRBP

CORBUS PHARMACEUTICALS HLDGS (CRBP)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001595097 · EDGAR filings · Updated 2026-07-27

CORBUS PHARMACEUTICALS HLDGS (CRBP) has reported institutional ownership of 72.3%, with 106 institutional managers holding positions valued at $120.5M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (2)

• 2026-07-27 — SCHEDULE 13G filed
• 2026-07-27 — Notice of proposed sale filed (Form 144)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-06 — Current report (8-K) filed
• 2026-06-17 — Employee-plan registration (S-8) filed
• 2026-06-11 — Insider transaction reported (Form 4)
• 2026-06-11 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CORBUS PHARMACEUTICALS HLDGS has 106 institutional holders and institutional ownership of 72.3%.

Insider activity

Insiders reported 27 transactions (0 buys, 13 sells) across 11 reporting insiders, with a net reported value of −$1.34M.

Data flags from SEC filings

Related companies

CRONOS GROUP INC (CRON) · Anavex Life Sciences (AVXL) · NKARTA INC (NKTX) · Whitehawk Therapeutics Inc (WHWK) · AGILON HEALTH INC (AGL) · THE ONCOLOGY INSTITUTE INC (TOI)